483
Solaris Pharma CorpSolaris Pharma Corp – FDA 483, Oct 31, 2019
Record Details
Sol-Gel Technologies Ltd. in Bridgewater, NJ, was inspected and cited for significant deficiencies in data integrity, deviation management, and equipment cleaning and maintenance. The firm lacked proper controls over computer systems, failed to investigate and document deviations from procedures, and did not maintain or clean laboratory equipment adequately. These issues indicate a lack of robust quality control and data integrity practices.
View Company Profile
ID · e583753a-c336-463d-90cf-63c98c7a3038
Other documents for Solaris Pharma Corp
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.